Parameters of Cerebral Perfusion
Not Applicable
Completed
- Conditions
- Cerebral PerfusionCerebral OxygenationCardiopulmonary Bypass
- Interventions
- Other: 50-100ug phenylephrine before CPBOther: 50-100ug phenylephrine during CPBOther: decreasing CPB flowOther: Decreasing CPB flow AND 50-100ug phenylephrineOther: Increasing CPB flow
- Registration Number
- NCT02806492
- Lead Sponsor
- UMC Utrecht
- Brief Summary
The purpose of this study is to determine whether cerebral blood flow and cerebral tissue oxygenation is most dependent on cardiac output or on mean arterial pressure in patients undergoing cardiac surgery with the use of cardiopulmonary bypass.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Undergoing cardiopulmonary bypass for CABG a
- having an appropriate temporal bone window for reliable TCD monitoring
- needing pharmacological intervention because of hypotension before going on CPB.
Exclusion Criteria
- requiring hypothermia during surgery
- requiring emergency surgery
- contraindication for phenylephrine,
- having known brain pathology (e.g. Cerebral Vascular Accident (CVA) or increased intracranial pressure
- having a history of severe carotid artery stenosis.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Patient for cardiac surgery Decreasing CPB flow AND 50-100ug phenylephrine All patient undergo the 5 different intervention in a randomised matter. Patient for cardiac surgery Increasing CPB flow All patient undergo the 5 different intervention in a randomised matter. Patient for cardiac surgery 50-100ug phenylephrine before CPB All patient undergo the 5 different intervention in a randomised matter. Patient for cardiac surgery 50-100ug phenylephrine during CPB All patient undergo the 5 different intervention in a randomised matter. Patient for cardiac surgery decreasing CPB flow All patient undergo the 5 different intervention in a randomised matter.
- Primary Outcome Measures
Name Time Method regional cerebral oxygen saturation During surgery mean velocity of blood flow of the middle cerebral artery During surgery
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UMC Utrecht
🇳🇱Utrecht, Netherlands